A Phase 3 Study to Evaluate Efficacy & Safety of Subcutaneous CT-P13 in Patients With Moderate to Severe Active Rheumatoid Arthritis

NCT06738719 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
192
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Celltrion